カテゴリー： Grand View Research, 世界, 医療/バイオ

組換えタンパク質製造サービスのグローバル市場2023-2030：前臨床＆臨床サービス、商業生産

◆英語タイトル：Recombinant Proteins Manufacturing Services Market Size, Share & Trends Analysis Report, By Service Type (Pre-clinical & Clinical Services, Commercial Production), By Host Cell, By End-user, By Region, And Segment Forecasts, 2023 - 2030
	◆商品コード：GRV23SEP054 ◆発行会社（リサーチ会社）：Grand View Research ◆発行日：2023年8月 ◆ページ数：180 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後3営業日） ◆調査対象地域：グローバル ◆産業分野：バイオテクノロジー

◆販売価格オプション（消費税別）

Single User	USD5,950 ⇒換算￥880,600	見積依頼/購入/質問フォーム
Multi User/Five User	USD6,950 ⇒換算￥1,028,600	見積依頼/購入/質問フォーム
Global/corporate License	USD8,950 ⇒換算￥1,324,600	見積依頼/購入/質問フォーム

★Grand View Researchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

組換えタンパク質製造サービス市場の成長と動向
Grand View Research, Inc.の最新レポートによると、組換えタンパク質製造サービスの世界市場規模は、2023年から2030年にかけて年平均成長率17.79%で推移し、2030年には127億4000万米ドルに達する見込みです。組換えタンパク質は、バイオテクノロジー研究や医学の分野で多くの用途があります。さらに、組換えタンパク質の製造は、ライフサイエンス分野で利用される効果的な手順の1つであり、高度なヘルスケアに大きな影響を与えています。

世界のヘルスケア産業は急速に拡大しており、さまざまな病気に対する新しい治療法を発見するための研究開発（R&D）への支出が促進されています。組換えタンパク質の生産は、ヘルスケア産業の拡大や生物製剤への支出と密接な関係があります。さらに、政府の支援は、バイオテクノロジー企業とともに学術機関の研究努力を奨励し、その結果、タンパク質市場の発展をもたらしました。例えば、2023年2月、欧州投資銀行（EIB）はInvestEUプログラムの支援を受け、エストニアのバイオ医薬品開発企業Icosagen ASに対し、創薬・開発・生産能力を拡大するために1,995万米ドル（1,800万ユーロ）の融資を行うことで合意しました。

さらに、遺伝子組換え技術の進歩に伴い、個別化医療、細胞・遺伝子治療、生物工学製品の開発に向けた遺伝子組換えタンパク質の新規用途が増加すると予測されています。例えば、CRISPR-Cas9のような遺伝子編集技術により、組換えタンパク質の正確な改変が可能になり、革新的な治療薬が開発されています。このような要因により、タンパク質の需要が大幅に増加し、製造サービス市場が牽引されると予想されます。

Lonza、GenScript、Merck KGaA、Kaneka Eurogentec S.A.、ExcellGene SA.など、複数の企業が組換えタンパク質の製造サービスを提供しており、アウトソーシング活動の成長が見込まれています。主要企業は、世界中で拡大するアウトソーシング需要に対応するため、製造能力を拡大しています。例えば、メルクKGaAは2022年10月、フランスのマルティヤックにミリポアCTDMOサービスの新しい商業施設を開設しました。この新しい施設は、モノクローナル抗体やその他の組換えタンパク質を含む医薬品を製造するために建設されました。同様に、2021年9月、抗体、免疫測定キット、ライフサイエンス研究用組換えタンパク質を製造・開発するアビバ・システム・バイオロジー社は、基礎研究および前臨床研究向けに、革新的なタンパク質オンデマンド、カスタマイズされたタンパク質投資ポートフォリオを開始しました。このような取り組みにより、今後10年間は市場に有利な成長機会が生まれると期待されています。

組み換えタンパク質製造サービス市場レポートハイライト

- サービスタイプ別では、商業生産サービスが2022年に58.60%の最大シェアを占めました。この背景には、高収率発現系へのアクセスが増加していることがあります。

- 宿主細胞別では、哺乳類セグメントが2022年に54.91%の最大シェアを占めました。製薬企業やバイオテクノロジー企業における哺乳類細胞への需要の高まりにより、市場は拡大しています。

- エンドユーザー別では、製薬・バイオテクノロジー企業が2022年に78.53%の最大シェアを占めました。組換えタンパク質はバイオテクノロジー＆製薬業界で絶大な支持を得ており、様々な病気のワクチンや治療法の開発、タンパク質製造関連サービスに利用されています。

- 北米は2022年に37.86%の最大シェアを占めました。これは主に、主要な市場参加者の存在と、地域全体の医療費の上昇によるものです。

第1章．調査手法＆範囲
第2章．エグゼクティブサマリー
第3章．市場変動・動向・範囲
第4章．サービス別分析
第5章．宿主細胞別分析
第6章．エンドユーザー別分析
第7章．地域別分析
第8章．競合状況

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Service Type Segment
1.2.2. Host Cell Segment
1.2.3. End-user Segment
1.3. Research Assumptions
1.4. Information Procurement
1.4.1. Primary Research
1.5. Information Or Data Analysis
1.6. Market Formulation & Validation
1.7. Market Model
1.8. Global Market: CAGR Calculation
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Increasing Adoption Of Outsourcing Models For Recombinant Protein Manufacturing
3.3.2. Increasing Scope Of Applications For Recombinant Protein-Based Products
3.3.3. Increasing Use Of Recombinant Proteins In Research-Use Activities
3.4. Market Restraint Analysis
3.4.1. Stringent Regulations Associated With Recombinant Protein-Based Biopharmaceuticals
3.5. Business Environment Analysis
3.5.1. PESTEL Analysis
3.5.2. Porter’s Five Forces Analysis
3.5.3. COVID-19 Impact Analysis
Chapter 4. Service Type Business Analysis
4.1. Global Recombinant Proteins Manufacturing Services Market: Service Type Movement Analysis
4.2. Pre-clinical & Clinical Services
4.2.1. Pre-clinical & Clinical Services Market, 2018 – 2030 (USD Million)
4.3. Commercial Production Services
4.3.1. Commercial Production Services Market, 2018 – 2030 (USD Million)
Chapter 5. Host Cell Business Analysis
5.1. Global Recombinant Proteins Manufacturing Services Market: Host Cell Movement Analysis
5.2. Mammalian Cells
5.2.1. Mammalian Cells Market, 2018 – 2030 (USD Million)
5.3. Bacterial Cells
5.3.1. Bacterial Cells Market, 2018 – 2030 (USD Million)
5.4. Insect Cells
5.4.1. Insect Cells Market, 2018 – 2030 (USD Million)
5.5. Yeast & Fungi
5.5.1. Yeast & Fungi Market, 2018 – 2030 (USD Million)
5.6. Others
5.6.1. Others Market, 2018 – 2030 (USD Million)
Chapter 6. End-User Business Analysis
6.1. Global Recombinant Proteins Manufacturing Services Market: End-User Movement Analysis
6.2. Pharmaceutical & Biotechnology Companies
6.2.1. Pharmaceutical & Biotechnology Companies Market, 2018 – 2030 (USD Million)
6.3. Academic & Research Institutes
6.3.1. Academic & Research Institutes Market, 2018 – 2030 (USD Million)
Chapter 7. Regional Business Analysis
7.1. Global Recombinant Proteins Manufacturing Services Market Share By Region, 2022 & 2030
7.2. North America
7.2.1. North America Recombinant Proteins Manufacturing Services Market, 2018 – 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. Key Country Dynamics
7.2.2.2. Competitive Scenario
7.2.2.3. Regulatory Framework
7.2.2.4. Target Disease Prevalence
7.2.2.5. U.S. Recombinant Proteins Manufacturing Services Market, 2018 – 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Key Country Dynamics
7.2.3.2. Competitive Scenario
7.2.3.3. Regulatory Framework
7.2.3.4. Target Disease Prevalence
7.2.3.5. Canada Recombinant Proteins Manufacturing Services Market, 2018 – 2030 (USD Million)
7.3. Europe
7.3.1. Europe Recombinant Proteins Manufacturing Services Market, 2018 – 2030 (USD Million)
7.3.2. Germany
7.3.2.1. Key Country Dynamics
7.3.2.2. Competitive Scenario
7.3.2.3. Regulatory Framework
7.3.2.4. Target Disease Prevalence
7.3.2.5. Germany Recombinant Proteins Manufacturing Services Market, 2018 – 2030 (USD Million)
7.3.3. UK
7.3.3.1. Key Country Dynamics
7.3.3.2. Competitive Scenario
7.3.3.3. Regulatory Framework
7.3.3.4. Target Disease Prevalence
7.3.3.5. UK Recombinant Proteins Manufacturing Services Market, 2018 – 2030 (USD Million)
7.3.4. France
7.3.4.1. Key Country Dynamics
7.3.4.2. Competitive Scenario
7.3.4.3. Regulatory Framework
7.3.4.4. Target Disease Prevalence
7.3.4.5. France Recombinant Proteins Manufacturing Services Market, 2018 – 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Key Country Dynamics
7.3.5.2. Competitive Scenario
7.3.5.3. Regulatory Framework
7.3.5.4. Target Disease Prevalence
7.3.5.5. Italy Recombinant Proteins Manufacturing Services Market, 2018 – 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Key Country Dynamics
7.3.6.2. Competitive Scenario
7.3.6.3. Regulatory Framework
7.3.6.4. Target Disease Prevalence
7.3.6.5. Spain Recombinant Proteins Manufacturing Services Market, 2018 – 2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Key Country Dynamics
7.3.7.2. Competitive Scenario
7.3.7.3. Regulatory Framework
7.3.7.4. Target Disease Prevalence
7.3.7.5. Denmark Recombinant Proteins Manufacturing Services Market, 2018 – 2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Key Country Dynamics
7.3.8.2. Competitive Scenario
7.3.8.3. Regulatory Framework
7.3.8.4. Target Disease Prevalence
7.3.8.5. Sweden Recombinant Proteins Manufacturing Services Market, 2018 – 2030 (USD Million)
7.3.9. Norway
7.3.9.1. Key Country Dynamics
7.3.9.2. Competitive Scenario
7.3.9.3. Regulatory Framework
7.3.9.4. Target Disease Prevalence
7.3.9.5. Norway Recombinant Proteins Manufacturing Services Market, 2018 – 2030 (USD Million)
7.3.10. Switzerland
7.3.10.1. Key Country Dynamics
7.3.10.2. Competitive Scenario
7.3.10.3. Regulatory Framework
7.3.10.4. Target Disease Prevalence
7.3.10.5. Switzerland Recombinant Proteins Manufacturing Services Market, 2018 – 2030 (USD Million)
7.3.11. Netherlands
7.3.11.1. Key Country Dynamics
7.3.11.2. Competitive Scenario
7.3.11.3. Regulatory Framework
7.3.11.4. Target Disease Prevalence
7.3.11.5. Netherlands Recombinant Proteins Manufacturing Services Market, 2018 – 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Recombinant Proteins Manufacturing Services Market, 2018 – 2030 (USD Million)
7.4.2. Japan
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Regulatory Framework
7.4.2.4. Target Disease Prevalence
7.4.2.5. Japan Recombinant Proteins Manufacturing Services Market, 2018 – 2030 (USD Million)
7.4.3. China
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Regulatory Framework
7.4.3.4. Target Disease Prevalence
7.4.3.5. China Recombinant Proteins Manufacturing Services Market, 2018 – 2030 (USD Million)
7.4.4. India
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Regulatory Framework
7.4.4.4. Target Disease Prevalence
7.4.4.5. India Recombinant Proteins Manufacturing Services Market, 2018 – 2030 (USD Million)
7.4.5. South Korea
7.4.5.1. Key Country Dynamics
7.4.5.2. Competitive Scenario
7.4.5.3. Regulatory Framework
7.4.5.4. Target Disease Prevalence
7.4.5.5. South Korea Recombinant Proteins Manufacturing Services Market, 2018 – 2030 (USD Million)
7.4.6. Australia
7.4.6.1. Key Country Dynamics
7.4.6.2. Competitive Scenario
7.4.6.3. Regulatory Framework
7.4.6.4. Target Disease Prevalence
7.4.6.5. Australia Recombinant Proteins Manufacturing Services Market, 2018 – 2030 (USD Million)
7.4.7. Thailand
7.4.7.1. Key Country Dynamics
7.4.7.2. Competitive Scenario
7.4.7.3. Regulatory Framework
7.4.7.4. Target Disease Prevalence
7.4.7.5. Thailand Recombinant Proteins Manufacturing Services Market, 2018 – 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Recombinant Proteins Manufacturing Services Market, 2018 – 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Framework
7.5.2.4. Target Disease Prevalence
7.5.2.5. Brazil Recombinant Proteins Manufacturing Services Market, 2018 – 2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. Target Disease Prevalence
7.5.3.5. Mexico Recombinant Proteins Manufacturing Services Market, 2018 – 2030 (USD Million)
7.5.4. Argentina
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Framework
7.5.4.4. Target Disease Prevalence
7.5.4.5. Argentina Recombinant Proteins Manufacturing Services Market, 2018 – 2030 (USD Million)
7.6. MEA
7.6.1. MEA Recombinant Proteins Manufacturing Services Market, 2018 – 2030 (USD Million)
7.6.2. South Africa
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. Target Disease Prevalence
7.6.2.5. South Africa Recombinant Proteins Manufacturing Services Market, 2018 – 2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. Target Disease Prevalence
7.6.3.5. Saudi Arabia Recombinant Proteins Manufacturing Services Market, 2018 – 2030 (USD Million)
7.6.4. UAE
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Regulatory Framework
7.6.4.4. Target Disease Prevalence
7.6.4.5. UAE Recombinant Proteins Manufacturing Services Market, 2018 – 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Regulatory Framework
7.6.5.4. Target Disease Prevalence
7.6.5.5. Kuwait Recombinant Proteins Manufacturing Services Market, 2018 – 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Share Analysis, 2022
8.4. Company Profiles/Listing
8.4.1. Lonza
8.4.1.1. Overview
8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Boehringer Ingelheim International GmbH
8.4.2.1. Overview
8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. FUJIFILM Diosynth Biotechnologies
8.4.3.1. Overview
8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Merck KGaA
8.4.4.1. Overview
8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Bruker (InVivo BioTech Services GmbH)
8.4.5.1. Overview
8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. Sino Biological, Inc.
8.4.6.1. Overview
8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. GenScript
8.4.7.1. Overview
8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Kaneka Corporation (Kaneka Eurogentec S.A)
8.4.8.1. Overview
8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. Polyplus Transfection (Xpress Biologics)
8.4.9.1. Overview
8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. Boster Biological Technology
8.4.10.1. Overview
8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives
8.4.11. Trenzyme GmbH
8.4.11.1. Overview
8.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.11.3. Product Benchmarking
8.4.11.4. Strategic Initiatives

List of Tables

Table 1 List Of Secondary Sources
Table 2 List Of Abbreviations
Table 3 Global Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 4 Global Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 5 Global Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 6 North America Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 7 North America Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 8 North America Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 9 North America Recombinant Proteins Manufacturing Services Market by Country, 2018 - 2030 (USD million)
Table 10 U.S. Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 11 U.S. Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 12 U.S. Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 13 Canada Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 14 Canada Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 15 Canada Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 16 Europe Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 17 Europe Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 18 Europe Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 19 Europe Recombinant Proteins Manufacturing Services Market by Country, 2018 - 2030 (USD million)
Table 20 UK Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 21 UK Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 22 UK Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 23 Germany Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 24 Germany Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 25 Germany Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 26 France Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 27 France Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 28 France Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 29 Italy Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 30 Italy Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 31 Italy Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 32 Spain Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 33 Spain Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 34 Spain Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 35 Denmark Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 36 Denmark Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 37 Denmark Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 38 Sweden Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 39 Sweden Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 40 Sweden Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 41 Norway Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 42 Norway Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 43 Norway Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 44 Switzerland Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 45 Switzerland Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 46 Switzerland Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 47 Netherlands Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 48 Netherlands Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 49 Netherlands Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 50 Asia Pacific Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 51 Asia Pacific Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 52 Asia Pacific Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 53 Asia Pacific Recombinant Proteins Manufacturing Services Market by Country, 2018 - 2030 (USD million)
Table 54 China Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 55 China Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 56 China Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 57 Japan Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 58 Japan Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 59 Japan Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 60 India Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 61 India Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 62 India Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 63 South Korea Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 64 South Korea Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 65 South Korea Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 66 Australia Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 67 Australia Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 68 Australia Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 69 Thailand Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 70 Thailand Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 71 Thailand Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 72 Thailand Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 73 Latin America Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 74 Latin America Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 75 Latin America Recombinant Proteins Manufacturing Services Market by Country, 2018 - 2030 (USD million)
Table 76 Brazil Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 77 Brazil Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 78 Brazil Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 79 Mexico Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 80 Mexico Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 81 Mexico Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 82 Argentina Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 83 Argentina Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 84 Argentina Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 85 Middle East & Africa Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 86 Middle East & Africa Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 87 Middle East & Africa Recombinant Proteins Manufacturing Services Market by Country, 2018 - 2030 (USD million)
Table 88 South Africa Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 89 South Africa Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 90 South Africa Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 91 Saudi Arabia Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 92 Saudi Arabia Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 93 Saudi Arabia Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 94 UAE Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 95 UAE Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 96 UAE Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 97 Kuwait Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 98 Kuwait Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD Million)
Table 99 Kuwait Recombinant Proteins Manufacturing Services Market By End-User, 2018 - 2030 (USD Million)
Table 100 Participant’s Overview
Table 101 Financial Performance
Table 102 Key Companies Undergoing Expansions
Table 103 Key Companies Undergoing Acquisitions
Table 104 Key Companies Undergoing Collaborations
Table 105 Key Companies Launching New Products/Services
Table 106 Key Companies Undergoing Partnerships
Table 107 Key Companies Undertaking Other Strategies

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 組換えタンパク質製造サービスのグローバル市場2023-2030：前臨床＆臨床サービス、商業生産(Recombinant Proteins Manufacturing Services Market Size, Share & Trends Analysis Report, By Service Type (Pre-clinical & Clinical Services, Commercial Production), By Host Cell, By End-user, By Region, And Segment Forecasts, 2023 - 2030)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

組換えタンパク質製造サービスのグローバル市場2023-2030：前臨床＆臨床サービス、商業生産

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp